{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T17:04:39Z","timestamp":1790355879944,"version":"4.1.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,4,18]],"date-time":"2020-04-18T00:00:00Z","timestamp":1587168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,4,18]],"date-time":"2020-04-18T00:00:00Z","timestamp":1587168000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Aging Clin Exp Res"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1007\/s40520-020-01554-8","type":"journal-article","created":{"date-parts":[[2020,4,18]],"date-time":"2020-04-18T19:02:47Z","timestamp":1587236567000},"page":"869-881","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":49,"title":["The role of neurofilament light chain in frontotemporal dementia: a meta-analysis"],"prefix":"10.1007","volume":"33","author":[{"given":"Eleni","family":"Karantali","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios","family":"Kazis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Symela","family":"Chatzikonstantinou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fivos","family":"Petridis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioannis","family":"Mavroudis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,4,18]]},"reference":[{"key":"1554_CR1","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1016\/S1474-4422(10)70195-2","volume":"9","author":"IRA Mackenzie","year":"2010","unstructured":"Mackenzie IRA, Rademakers R, Neumann M (2010) TDP-43 and FUS in amyotrophic lateral sclerosis and frontotemporal dementia. Lancet Neurol 9:995\u20131007","journal-title":"Lancet Neurol"},{"key":"1554_CR2","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s00401-011-0845-8","volume":"122","author":"IRA Mackenzie","year":"2011","unstructured":"Mackenzie IRA, Neumann M, Baborie A et al (2011) A harmonized classification system for FTLD-TDP pathology. Acta Neuropathol 122:111\u2013113","journal-title":"Acta Neuropathol"},{"key":"1554_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00401-009-0612-2","volume":"119","author":"IRA MacKenzie","year":"2010","unstructured":"MacKenzie IRA, Neumann M, Bigio EH et al (2010) Nomenclature and nosology for neuropathologic subtypes of frontotemporal lobar degeneration: an update.\u00a0Acta Neuropathol 119:1\u20134","journal-title":"Acta Neuropathol"},{"key":"1554_CR4","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1007\/s00401-009-0593-1","volume":"118","author":"IE Holm","year":"2009","unstructured":"Holm IE, Isaacs AM, MacKenzie IRA (2009) Absence of FUS-immunoreactive pathology in frontotemporal dementia linked to chromosome 3 (FTD-3) caused by mutation in the CHMP2B gene. Acta Neuropathol 118:719\u2013720","journal-title":"Acta Neuropathol"},{"key":"1554_CR5","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1136\/jnnp-2018-320106","volume":"90","author":"L Gaetani","year":"2019","unstructured":"Gaetani L, Blennow K, Calabresi P et al (2019) Neurofilament light chain as a biomarker in neurological disorders.\u00a0J Neurol Neurosurg Psychiatr 90:870\u2013881. https:\/\/doi.org\/10.1136\/jnnp-2018-320106","journal-title":"J Neurol Neurosurg Psychiatr"},{"key":"1554_CR6","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1038\/s41582-018-0058-z","volume":"14","author":"M Khalil","year":"2018","unstructured":"Khalil M, Teunissen CE, Otto M et al (2018) Neurofilaments as biomarkers in neurological disorders. Nat Rev Neurol 14:577\u2013589. https:\/\/doi.org\/10.1038\/s41582-018-0058-z","journal-title":"Nat Rev Neurol"},{"key":"1554_CR7","doi-asserted-by":"publisher","DOI":"10.1177\/0004867419857811","author":"D Eratne","year":"2019","unstructured":"Eratne D, Loi SM, Walia N et al (2019) A pilot study of the utility of cerebrospinal fluid neurofilament light chain in differentiating neurodegenerative from psychiatric disorders: a \u2018C-reactive protein\u2019 for psychiatrists and neurologists? Aust N Z J Psychiatry. https:\/\/doi.org\/10.1177\/0004867419857811","journal-title":"Aust N Z J Psychiatry"},{"key":"1554_CR8","doi-asserted-by":"publisher","first-page":"e1000100","DOI":"10.1371\/journal.pmed.1000100","volume":"6","author":"A Liberati","year":"2009","unstructured":"Liberati A, Altman DG, Tetzlaff J et al (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med 6:e1000100. https:\/\/doi.org\/10.1371\/journal.pmed.1000100","journal-title":"PLoS Med"},{"key":"1554_CR9","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-5-13","author":"SP Hozo","year":"2005","unstructured":"Hozo SP, Djulbegovic B, Hozo I (2005) Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol. https:\/\/doi.org\/10.1186\/1471-2288-5-13","journal-title":"BMC Med Res Methodol"},{"key":"1554_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2377-13-54","author":"M Landqvist Wald\u00f6","year":"2013","unstructured":"Landqvist Wald\u00f6 M, Frizell Santillo A, Passant U et al (2013) Cerebrospinal fluid neurofilament light chain protein levels in subtypes of frontotemporal dementia. BMC Neurol. https:\/\/doi.org\/10.1186\/1471-2377-13-54","journal-title":"BMC Neurol"},{"key":"1554_CR11","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-180409","author":"S Abu-Rumeileh","year":"2018","unstructured":"Abu-Rumeileh S, Mometto N, Bartoletti-Stella A et al (2018) Cerebrospinal fluid biomarkers in patients with frontotemporal dementia spectrum: a single-center study. J Alzheimer\u2019s Dis. https:\/\/doi.org\/10.3233\/JAD-180409","journal-title":"J Alzheimer\u2019s Dis"},{"key":"1554_CR12","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.2006.107326","author":"D De Jong","year":"2007","unstructured":"De Jong D, Jansen RWMM, Pijnenburg YAL et al (2007) CSF neurofilament proteins in the differential diagnosis of dementia. J Neurol Neurosurg Psychiatry. https:\/\/doi.org\/10.1136\/jnnp.2006.107326","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1554_CR13","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1159\/000099473","volume":"23","author":"YAL Pijnenburg","year":"2007","unstructured":"Pijnenburg YAL, Janssen JC, Schoonenboom NSM et al (2007) CSF neurofilaments in frontotemporal dementia compared with early onset Alzheimer\u2019s disease and controls. Dement Geriatr Cogn Disord 23:225\u2013230. https:\/\/doi.org\/10.1159\/000099473","journal-title":"Dement Geriatr Cogn Disord"},{"key":"1554_CR14","doi-asserted-by":"publisher","DOI":"10.1002\/hbm.24925","author":"N Falg\u00e0s","year":"2020","unstructured":"Falg\u00e0s N, Ruiz-Peris M, P\u00e9rez-Millan A et al (2020) Contribution of CSF biomarkers to early-onset Alzheimer\u2019s disease and frontotemporal dementia neuroimaging signatures. Hum Brain Mapp. https:\/\/doi.org\/10.1002\/hbm.24925","journal-title":"Hum Brain Mapp"},{"key":"1554_CR15","doi-asserted-by":"publisher","DOI":"10.1002\/acn3.643","author":"PA Ljubenkov","year":"2018","unstructured":"Ljubenkov PA, Staffaroni AM, Rojas JC et al (2018) Cerebrospinal fluid biomarkers predict frontotemporal dementia trajectory. Ann Clin Transl Neurol. https:\/\/doi.org\/10.1002\/acn3.643","journal-title":"Ann Clin Transl Neurol"},{"key":"1554_CR16","doi-asserted-by":"publisher","DOI":"10.1080\/21678421.2017.1281962","author":"T Skillb\u00e4ck","year":"2017","unstructured":"Skillb\u00e4ck T, Mattsson N, Blennow K, Zetterberg H (2017) Cerebrospinal fluid neurofilament light concentration in motor neuron disease and frontotemporal dementia predicts survival. Amyotroph Lateral Scler Front Degener. https:\/\/doi.org\/10.1080\/21678421.2017.1281962","journal-title":"Amyotroph Lateral Scler Front Degener"},{"key":"1554_CR17","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000001015","author":"T Skillb\u00e4ck","year":"2014","unstructured":"Skillb\u00e4ck T, Farahmand B, Bartlett JW et al (2014) CSF neurofilament light differs in neurodegenerative diseases and predicts severity and survival. Neurology. https:\/\/doi.org\/10.1212\/WNL.0000000000001015","journal-title":"Neurology"},{"key":"1554_CR18","doi-asserted-by":"publisher","first-page":"723","DOI":"10.3233\/JAD-181012","volume":"68","author":"S Abu-Rumeileh","year":"2019","unstructured":"Abu-Rumeileh S, Giannini G, Polischi B et al (2019) Revisiting the cerebrospinal fluid biomarker profile in idiopathic normal pressure hydrocephalus: the bologna pro-hydro study. J Alzheimer\u2019s Dis 68:723\u2013733. https:\/\/doi.org\/10.3233\/JAD-181012","journal-title":"J Alzheimer\u2019s Dis"},{"key":"1554_CR19","doi-asserted-by":"publisher","DOI":"10.1002\/ana.24052","author":"CS Scherling","year":"2014","unstructured":"Scherling CS, Hall T, Berisha F et al (2014) Cerebrospinal fluid neurofilament concentration reflects disease severity in frontotemporal degeneration. Ann Neurol. https:\/\/doi.org\/10.1002\/ana.24052","journal-title":"Ann Neurol"},{"key":"1554_CR20","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1136\/jnnp-2015-312972","volume":"87","author":"C Wilke","year":"2016","unstructured":"Wilke C, Preische O, Deuschle C et al (2016) Neurofilament light chain in FTD is elevated not only in cerebrospinal fluid, but also in serum. J Neurol Neurosurg Psychiatry 87:1270\u20131272. https:\/\/doi.org\/10.1136\/jnnp-2015-312972","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1554_CR21","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2014-309562","author":"NK Magdalinou","year":"2015","unstructured":"Magdalinou NK, Paterson RW, Schott JM et al (2015) A panel of nine cerebrospinal fluid biomarkers may identify patients with atypical parkinsonian syndromes. J Neurol Neurosurg Psychiatry. https:\/\/doi.org\/10.1136\/jnnp-2014-309562","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1554_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2017.11.015","author":"H Hampel","year":"2018","unstructured":"Hampel H, Toschi N, Baldacci F et al (2018) Alzheimer\u2019s disease biomarker-guided diagnostic workflow using the added value of six combined cerebrospinal fluid candidates: A\u03b2 1\u201342, total-tau, phosphorylated-tau, NFL, neurogranin, and YKL-40. Alzheimer\u2019s Dement. https:\/\/doi.org\/10.1016\/j.jalz.2017.11.015","journal-title":"Alzheimer\u2019s Dement"},{"key":"1554_CR23","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2016.5398","author":"A Gaiani","year":"2017","unstructured":"Gaiani A, Martinelli I, Bello L et al (2017) Diagnostic and prognostic biomarkers in amyotrophic lateral sclerosis. JAMA Neurol. https:\/\/doi.org\/10.1001\/jamaneurol.2016.5398","journal-title":"JAMA Neurol"},{"key":"1554_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-018-0364-0","author":"J Goossens","year":"2018","unstructured":"Goossens J, Bjerke M, Van Mossevelde S et al (2018) Diagnostic value of cerebrospinal fluid tau, neurofilament, and progranulin in definite frontotemporal lobar degeneration. Alzheimer\u2019s Res Ther. https:\/\/doi.org\/10.1186\/s13195-018-0364-0","journal-title":"Alzheimer\u2019s Res Ther"},{"key":"1554_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2018.00504","author":"P K\u00f6rtvelyessy","year":"2018","unstructured":"K\u00f6rtvelyessy P, Heinze HJ, Prudlo J, Bittner D (2018) CSF biomarkers of neurodegeneration in progressive non-fluent aphasia and other forms of frontotemporal dementia: clues for pathomechanisms? Front Neurol. https:\/\/doi.org\/10.3389\/fneur.2018.00504","journal-title":"Front Neurol"},{"key":"1554_CR26","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-018-0361-3","author":"RW Paterson","year":"2018","unstructured":"Paterson RW, Slattery CF, Poole T et al (2018) Cerebrospinal fluid in the differential diagnosis of Alzheimer\u2019s disease: clinical utility of an extended panel of biomarkers in a specialist cognitive clinic. Alzheimer\u2019s Res Ther. https:\/\/doi.org\/10.1186\/s13195-018-0361-3","journal-title":"Alzheimer\u2019s Res Ther"},{"key":"1554_CR27","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1002\/acn3.559","volume":"5","author":"LHH Meeter","year":"2018","unstructured":"Meeter LHH, Gendron TF, Sias AC et al (2018) Poly(GP), neurofilament and grey matter deficits in C9orf72 expansion carriers. Ann Clin Transl Neurol 5:583\u2013597. https:\/\/doi.org\/10.1002\/acn3.559","journal-title":"Ann Clin Transl Neurol"},{"key":"1554_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpsychires.2019.03.019","author":"MR Al Shweiki","year":"2019","unstructured":"Al Shweiki MR, Steinacker P, Oeckl P et al (2019) Neurofilament light chain as a blood biomarker to differentiate psychiatric disorders from behavioural variant frontotemporal dementia. J Psychiatr Res. https:\/\/doi.org\/10.1016\/j.jpsychires.2019.03.019","journal-title":"J Psychiatr Res"},{"key":"1554_CR29","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1212\/WNL.0000000000003154","volume":"87","author":"JD Rohrer","year":"2016","unstructured":"Rohrer JD, Woollacott IOC, Dick KM et al (2016) Serum neurofilament light chain protein is a measure of disease intensity in frontotemporal dementia. Neurology 87:1329\u20131336. https:\/\/doi.org\/10.1212\/WNL.0000000000003154","journal-title":"Neurology"},{"key":"1554_CR30","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-190838","author":"JA Mat\u00edas-Guiu","year":"2019","unstructured":"Mat\u00edas-Guiu JA, G\u00f3mez-Pinedo U, Forero L et al (2019) Plasma neurofilament light chain in primary progressive aphasia and related disorders: clinical significance and metabolic correlates. J Alzheimer\u2019s Dis. https:\/\/doi.org\/10.3233\/JAD-190838","journal-title":"J Alzheimer\u2019s Dis"},{"key":"1554_CR31","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000006318","author":"P Steinacker","year":"2018","unstructured":"Steinacker P, Anderl-Straub S, Diehl-Schmid J et al (2018) Serum neurofilament light chain in behavioral variant frontotemporal dementia. Neurology. https:\/\/doi.org\/10.1212\/WNL.0000000000006318","journal-title":"Neurology"},{"key":"1554_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(19)30354-0","author":"EL van der Ende","year":"2019","unstructured":"van der Ende EL, Meeter LH, Poos JM et al (2019) Serum neurofilament light chain in genetic frontotemporal dementia: a longitudinal, multicentre cohort study. Lancet Neurol. https:\/\/doi.org\/10.1016\/S1474-4422(19)30354-0","journal-title":"Lancet Neurol"},{"key":"1554_CR33","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2019-321954","author":"C Heller","year":"2020","unstructured":"Heller C, Foiani MS, Moore K et al (2020) Plasma glial fibrillary acidic protein is raised in progranulin-associated frontotemporal dementia. J Neurol Neurosurg Psychiatry. https:\/\/doi.org\/10.1136\/jnnp-2019-321954","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1554_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2016.05.018","author":"M Bacioglu","year":"2016","unstructured":"Bacioglu M, Maia LF, Preische O et al (2016) Neurofilament light chain in blood and CSF as marker of disease progression in mouse models and in neurodegenerative diseases. Neuron. https:\/\/doi.org\/10.1016\/j.neuron.2016.05.018","journal-title":"Neuron"},{"key":"1554_CR35","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1159\/000488681","volume":"18","author":"ZY Gong","year":"2018","unstructured":"Gong ZY, Lv GP, Gao LN et al (2018) Neurofilament subunit L levels in the cerebrospinal fluid and serum of patients with amyotrophic lateral sclerosis. Neurodegener Dis 18:165\u2013172. https:\/\/doi.org\/10.1159\/000488681","journal-title":"Neurodegener Dis"},{"key":"1554_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2018.12.042","author":"F Pujol-Calder\u00f3n","year":"2019","unstructured":"Pujol-Calder\u00f3n F, Portelius E, Zetterberg H et al (2019) Neurofilament changes in serum and cerebrospinal fluid after acute ischemic stroke. Neurosci Lett. https:\/\/doi.org\/10.1016\/j.neulet.2018.12.042","journal-title":"Neurosci Lett"},{"key":"1554_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.dadm.2015.11.001","author":"YAL Pijnenburg","year":"2015","unstructured":"Pijnenburg YAL, Verwey NA, van der Flier WM et al (2015) Discriminative and prognostic potential of cerebrospinal fluid phosphoTau\/tau ratio and neurofilaments for frontotemporal dementia subtypes. Alzheimer\u2019s Dement Diagnosis Assess Dis Monit. https:\/\/doi.org\/10.1016\/j.dadm.2015.11.001","journal-title":"Alzheimer\u2019s Dement Diagnosis Assess Dis Monit"},{"key":"1554_CR38","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.neuint.2017.05.010","volume":"108","author":"S Lista","year":"2017","unstructured":"Lista S, Toschi N, Baldacci F et al (2017) Diagnostic accuracy of CSF neurofilament light chain protein in the biomarker-guided classification system for Alzheimer\u2019s disease. Neurochem Int 108:355\u2013360. https:\/\/doi.org\/10.1016\/j.neuint.2017.05.010","journal-title":"Neurochem Int"},{"key":"1554_CR39","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000004088","author":"D Alcolea","year":"2017","unstructured":"Alcolea D, Vilaplana E, Su\u00e1rez-Calvet M et al (2017) CSF sAPP\u03b2, YKL-40, and neurofilament light in frontotemporal lobar degeneration. Neurology. https:\/\/doi.org\/10.1212\/WNL.0000000000004088","journal-title":"Neurology"},{"key":"1554_CR40","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-019-09567-8","author":"K Katisko","year":"2020","unstructured":"Katisko K, Cajanus A, J\u00e4\u00e4skel\u00e4inen O et al (2020) Serum neurofilament light chain is a discriminative biomarker between frontotemporal lobar degeneration and primary psychiatric disorders. J Neurol. https:\/\/doi.org\/10.1007\/s00415-019-09567-8","journal-title":"J Neurol"},{"key":"1554_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpsychires.2018.07.014","author":"LM Reus","year":"2018","unstructured":"Reus LM, Vijverberg EG, Tijms BM et al (2018) Disease trajectories in behavioural variant frontotemporal dementia, primary psychiatric and other neurodegenerative disorders presenting with behavioural change. J Psychiatr Res. https:\/\/doi.org\/10.1016\/j.jpsychires.2018.07.014","journal-title":"J Psychiatr Res"},{"key":"1554_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.dadm.2017.01.009","author":"EGB Vijverberg","year":"2017","unstructured":"Vijverberg EGB, Dols A, Krudop WA et al (2017) Cerebrospinal fluid biomarker examination as a tool to discriminate behavioral variant frontotemporal dementia from primary psychiatric disorders. Alzheimer\u2019s Dement Diagnosis Assess Dis Monit. https:\/\/doi.org\/10.1016\/j.dadm.2017.01.009","journal-title":"Alzheimer\u2019s Dement Diagnosis Assess Dis Monit"},{"key":"1554_CR43","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1002\/acn3.325","volume":"3","author":"LH Meeter","year":"2016","unstructured":"Meeter LH, Dopper EG, Jiskoot LC et al (2016) Neurofilament light chain: a biomarker for genetic frontotemporal dementia. Ann Clin Transl Neurol 3:623\u2013636. https:\/\/doi.org\/10.1002\/acn3.325","journal-title":"Ann Clin Transl Neurol"},{"key":"1554_CR44","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-017-0331-1","author":"S Abu-Rumeileh","year":"2018","unstructured":"Abu-Rumeileh S, Capellari S, Stanzani-Maserati M et al (2018) The CSF neurofilament light signature in rapidly progressive neurodegenerative dementias. Alzheimer\u2019s Res Ther. https:\/\/doi.org\/10.1186\/s13195-017-0331-1","journal-title":"Alzheimer\u2019s Res Ther"},{"key":"1554_CR45","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1212\/WNL.0000000000003680","volume":"88","author":"O Hansson","year":"2017","unstructured":"Hansson O, Janelidze S, Hall S et al (2017) Blood-based NfL: a biomarker for differential diagnosis of parkinsonian disorder. Neurology 88:930\u2013937. https:\/\/doi.org\/10.1212\/WNL.0000000000003680","journal-title":"Neurology"}],"container-title":["Aging Clinical and Experimental Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40520-020-01554-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40520-020-01554-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40520-020-01554-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,29]],"date-time":"2021-04-29T05:41:12Z","timestamp":1619674872000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40520-020-01554-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,18]]},"references-count":45,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["1554"],"URL":"https:\/\/doi.org\/10.1007\/s40520-020-01554-8","relation":{},"ISSN":["1720-8319"],"issn-type":[{"value":"1720-8319","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,18]]},"assertion":[{"value":"7 December 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The corresponding authors state that there is no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statement of human and animal rights"}},{"value":"For this type of study, formal consent is not required.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}